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Bries D e 6 n i t l v e R e p o r t

Human Osteoblasts Support Hematopoiesis through
the Production of Granulocyte Colony-stimulating
Factor
By Russell S. Taichman,* and StephenG. Emerson~
From the Departments of *Periodontics, Prevention, and Geriatrics, and ~Internal Medicine,
University of Michigan, Ann Arbor, Michigan

Summary

ematopoietic stem cell differentiation after birth is largely
restricted to the bone marrow cavity. Whether osteoH
blasts and bone matrix provide essential adhesive, stimulatory, or regulatory signals to stem cells is not known. Overall,
the unique physiological conditions that bone tissue provides
for hematopoietic cells is essentially a mystery. Mesenchymal
cells of fibroblast origin, dispersed throughout the marrow
cavity, secrete cytokines such as GM-CSF, IL-6, and c-kit ligand
to support basal hematopoiesis, and respond to inflammatory monokines by secreting large quantities of GM-CSF and
G-CSF (1-7). This cytokine secretion profile is not, however, specific to bone marrow and is shared by fibroblasts from
many tissues. In addition, in the absence of inflammation
human fibroblasts do not produce G-CSF, and the source of
basal G-CSF production that supports normal granulopoiesis is unknown (6, 7).
The development of the bone marrow cavity is a coordinated process in which blood precursors migrate and colonize spaces carved out of embryonic bone and cartilage (8).
Thus, an intimate physical association between bone cells and
blood cells is established early in life. Since (a) osteoblasts
are found on endosteal marrow surfaces; (b) primitive hematopoietic stem cells are closely approximated with the endosteal surfaces rather than randomly distributed throughout
the marrow cavity; and (c) many stromal cell lines share several phenotypic characteristics with osteoblasts (9-14), we
hypothesized that osteoblasts might directly support stem
cell survival and/or differentiation. In particular we asked
whether osteoblasts might be a heretofore undetermined source
of constitutively produced G-CSF in the bone marrow
microenvironment.
1677

Materials and Methods
Human Osteoblasts. "Human osteoblasts were obtained using a
modification of methods described by Robey and Termine (15).
Normal human trabecular bone was obtained from patients undergoing orthopedic surgery in accordance with the University of
Michigan's Policies for Human Subjects. Bone cleaned of loosely
adherent tissue was ground to produce a uniform particle size (size
~<1 mm 2) (BioComp MinimiU; W. Lorenz, Jacksonville, FL) and
incubated in 1 mg/ml bacterial coUagenase (Type P; Boehringer
Mannheim Biologicals, Indianapolis, IN). The explants were placed
into culture until confluent monolayers were produced in a 1:1
(vol/vol) mixture of F12/DMEM medium (Biofluids Inc., Rockville, MD) with low Ca +2 and 10% FCS. Thereafter, cultures
were maintained in calcium-replete DMEM/F12 (1:1 vol/vol)
medium containing 10% heat inactivated FCS, antibiotics, 10 mM
B-glycerophosphate, and 10 mg/ml t-ascorbate. To verify that the
cells were osteoblasts, several histochemical assays were performed
including in vitro mineralization, and expression of high levels of
alkaline phosphatase (16).
RNA Preparation. Total cellular KNA was recovered from osteoblasts as reported in (7). RNA quantity and integrity were
checked by gel electrophoresis with ethidium bromide and absorbance at A~/A2s0.
Oligonucleotide Primers. Senseand antisense primers were prepared by the oligonucleotide synthesis core at the University of
Michigan. The primers used in these investigations were reported
previously (7) with the exceptions of those for osteocalcin (nucleotides 1046-1066 sense) GGCAGCGAGGTAGTGAAGAG
and (nucleotides 1364-1384, antisense) GATGTGGTCAGCCAACTCGT.
Reverse Transc@tasePolymerase Chain Reaction (RT-PCR). RTPCtL was performed for 35 cycles as previously reported (7). PCR
products were electrophoresed in 3% agarose and visualized with
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Previous attempts at identifying the constitutive source(s) of granulocyte colony-stimulating factor
(G-CSF) in human bone marrow have been unsuccessful despite the fact that normal bone marrow
supports abundant myelopoiesis in vivo. We hypothesized that the intimate physical association
between bone and hematopoietic cells facilitates interactions between osteoblasts and hematopoietic
stem cells. Here we provide the first direct evidence that human osteoblasts participate in
hematopoiesis by constitutively producing G-CSF and present the protein in a membrane-associated
fashion to human hematopoietic progenitors. These results suggest a direct and central role for
osteoblasts in normal myelopoiesis.
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Results and Discussion
We first determined whether unstimulated primary human
osteoblasts are a normal source of G-CSF. Primary osteoblasts
were obtained using the methods of Robey and Termine (15),
where osteoblasts emerge from collagenase-digested human
bone during the second to third week of culture. We found
that these cells express several functional characteristics of osteoblasts including the expression of m R N A for matrix Gla
protein (not shown) and the osteoblast-specific protein, osteocalcin (bone Gla protein) (16-18) (Fig. 1), mineralization
of their extracellular matrix, and the expression of alkaline
phosphatase examined by histochemical methods (data not
shown) (16).
Primary human osteoblast cultures were examined for their
1678

Figure 1. RT-PCRdetectionofcytokinemRNAby (A) primaryhuman
osteoblasts and (B) stromalcells. RT-PCRwas performedusing primers
forIL-Ic~,TNF, lymphotoxin(LT),IL-6,G-CSF,GM-CSF,IL-3,c-kit ligand,
and osteocalcin.Negativecontrolsomittedreversetranscriptasefrom the
reverse transcriptionreaction. RNA from IL-13 and TNF-c~ stimulated
stromal cells served as positive controls for G-CSF and c-kit ligand.

expression of mRNA for several cytokines using RT-PCR.
As shown in Fig. 1, osteoblasts constitutively express mRNA
for several cytokines including TNF-a, IL-6, GM-CSF, and
G-CSF, but failed to express m R N A for IL-loe, IL-3, and
c-kit ligand. As c-kit ligand is constitutively produced by
stromal fibroblasts, the absence of detectable m R N A for this
hematopoietic growth factor suggests minimal fibroblast contamination in the primary cultures (Fig. 1 and 4, 6, 7). To
further assure that these results are representative of normal
osteoblast physiology, we induced the differentiation of osteoblasts from nonadherent low density bone marrow osteoprogenitors using a serum deprivation method (19). A
similar cytokine profile was observed for these osteocalcin +,
c-kit ligand- cells. In addition, we noted a comparable pat-
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ethidium bromide. As positive cytokine controls, RNA was isolated from either peripheral blood lymphocytes stimulated with
PHA (3.0 #g/ml) and PMA (3 ng/ml) or IL-lc~(25 U/m1) stimulated human bone marrow stromal cells. To control for DNA contamination, reverse transcriptase was omitted from the reverse transcriptase reaction.
ELISAs. G-CSF ELISAs were performed using the doubleantibody sandwich method (R&D SystemsInc., Minneapolis,MN).
Based upon parallel assays of known diluted standards, the sensitivities of the assays for G-CSF in unconcentrated medium is
25-2,000 pg/ml. Aliquots of conditioned medium were concentrated 4-10-fold by centrifugation at 1,000 g in a 25~ fixed angle
JA-17 rotor (Beckman Instruments Inc., Fullerton, CA) in Centricon-10 concentrators (Amicon Division ofW. R. Grace and Co.,
Beverly, MA) until the desired volume was reached. Used in conjunction with concentrated medium, the G-CSF ELISA was able
to detect concentrations as low as 4 pg/ml.
Immunohistochemistry. Indirect immunohistochemistry phasecontrast microscopywas performed for G-CSF on 2% paraformaldehyde-fixedprimary human osteoblasts grown in 96-well tissue culture plates. Paraformaldehyde-fixedprimary human osteoblastswere
incubated with 10/~g/ml of a murine monoclonal anti-human
G-CSF in PBS (M7; kind gift of Dr. Michael Widmer, Immunex
Corporation, Seattle, WA) or an isotype control (FOPC-21, Sigma
Chemical Co., St. Louis, MO) at 4~ for two hours followed by
a rabbit antimurine FITC-conjugated serum at a 1/64 dilution
(Sigma Chemical Co.). Nonspecificbinding was blocked with 10%
normal rabbit serum.
Isolation of CD34 + Cells. Bone marrow cells obtained from
healthy adult volunteers were diluted 1:4 (vol/vol) in IMDM and
separated by density separation on Ficoll-Hypaque (specificgravity
1.077) to recover mononuclear cells. After two rounds of plastic
adherence at 370C for 1 h each in IMDM medium with 20% FCS
(to remove monocytes, platelets, and megakaryocytes),the nonadherent cells were recovered. CD34 § hematopoietic progenitor
populations were isolated using an avidin-biotin immunoaffinity
process (CellPro Inc., Bothell, WA).
Coculture of NFS-60, CD34 +, and Osteoblasts. CD34+ or NFS60 cells were seeded directly onto osteocalcin+, c-kit ligandconfluent osteoblast monolayersin 96-well tissue culture plates at
a final density of 104 cells/well and incubated for 3-14 d. Either
vehicle, 10 #g/weU of an a~nity purifiedIgG fractionof neutralizing
goat anti-human G-CSF serum (R&D Systems), or 10/~g/well
of normal goat IgG serum were added to cultures daily. Absolute
cell numbers were determined by manual hemocytometer counting
in PBS containing 0.4% trypan blue (Sigma Chemical Co.).
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tern of cytokine mRNAs expressed by the human osteosarcoma cell lines, MG-63 and SaOSo2 (data not shown).
The ILT-PCR results suggest that osteoblasts constitutively
express G-CSF mRNA. We next asked whether the G-CSF
message is translated and how the protein is presented to heo
matopoietic progenitors. To determine whether the G-CSF
message is translated, we performed immunohistochemical
staining for G-CSF on paraformaldehyde-fixed primary human
osteoblasts using a monoclonal anti-human G-CSF antibody.
As shown in Fig. 2, G-CSF is localized on the cell membrane
of the osteoblasts and not in the interstitial extracellular matrix. To quantify G-CSF production from unstimulated osteoblasts expressing G-CSF mRNA, salt extracts of extracellular matrix (20, 21) and concentrated, conditioned medium
were analyzed for G-CSF by ELISA (7). As positive controls
for G-CSF production, osteoblasts or stromal cells were exposed to lipopolysaccharide or IL-lc~, respectively (22-24).
LPS stimulation of osteoblasts resulted in the production of
21 pg/ml/24 h/104 cells of soluble G-CSF. No G-CSF could
be detected in the medium or extracellular matrix of unstimulated osteoblasts, suggesting that under basal conditions GCSF may not be released as a soluble protein.
To determine whether the G-CSF detected by immunohistochemical methods has functional activity, we evaluated
the proliferation of the G-CSF-dependent cell line NFS-60
in coculture with osteocalcin +, c-kit ligand- human explant
osteoblasts (25). A neutralizing antibody to human G-CSF
was used to directly test whether osteoblast-derived G-CSF
has biological activity. As shown in Fig. 3, NFS-60 cells
proliferate in the presence of osteoblast monolayers but not
in medium alone. Inclusion of a neutralizing anti-G-CSF an1679

tibody in the cultures caused a 41% reduction in the proliferation of the NFS-60 cells. The proliferation of NFS-60 cells
was not affected by a control antiserum nor were significant
differences in proliferation of the NFS-60 cells observed when
the cells were grown in osteoblast-conditioned medium (50%
vol/vol) alone, with or without the neutralizing anti-human
G-CSF antibody.
These results obtained with the NFS-60 cell line suggest
that osteoblasts might stimulate the proliferation of human
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Figure 3. NFS-60cell proliferationon osteoblastmonolayers.NFS-60
cells were seededonto confluenthuman osteoblasts at a final density of
104cells/wellin 96-welltissue cultureplates for 3 d. Where indicatedvehicle(no AB), 10/zg/wellof an affinitypurifiedIgG fractionof neutralizing
goat anti-human G-CSF serum (Anti-G-CSF)or 10/~g/we11of normal
goat IgG serum (control AB) were added daily. Absolute NFS-60 cell
numbersweredeterminedby manualhemocytometercountingand reported
as mean _+ SD (n = 4). (Asterisk) Significantdifferencefrom antibody
or vehiclecontrol, p <0.01.
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Figure 2. Immunohistochemicaldetection of G-CSF on osteoblastcell surfaces. 2% paraformaldehyde-fixedprimary human osteoblasts (A) were incubated with (C) 10/~g/ml of routine monoclonalanti-human G-CSF in PBS or (B) an isotypecontrol at 4~ for 2 h followedby a rabbit antimurine
FITC-conjugated serum at a 1:64 dilution (Sigma Chemical Co.). Nonspecificbinding was blockedwith 10% normal rabbit serum.
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hematopoietic progenitors by producing G-CSF. To examine
this possibility, CD34 + hematopoietic progenitor cells were
isolated and seeded into confluent osteocalcin +, c-kit ligandosteoblast monolayers. At 14 d the hematopoietic cells were
recovered and counted. The significance of G-CSF in this
system was tested by the addition of an antiserum to human
G-CSF. An eightfold increase in cell recovery was observed
for hematopoietic cells grown in coculture with osteoblasts
over a 2-wk period (Fig. 4). 55.4% of the osteoblast-induced
increase in cell recovery was directly blocked by coincubation of neutralizing anti-G-CSF antibody in the culture. It
is interesting that 44.5% of the growth activity produced
by osteoblasts was not due to G-CSF, either alone or in combination with other osteoblast-derived cytokines. Furthermore, in Wright-Geimsa cytospin preparations many of the
hematopoietic cells recovered after 2 wk of coculture maintained an immature morphology (23 _ 6% myeloblasts/
promyelocytes; 51.7 _+ 5.5% myelocytes/metamyelocytes;
21 _+ 5% bands/polymorphonudear neutrophils; 4.3 _ 0.6%
monocytes). These data suggest that osteoblasts might produce additional factors that support the survival and limited
proliferation of primitive myeloid cells as well.
The biologic data using CD34 + and the NFS-60 cell line
in conjunction with the mRNA, and immunohistochemistry
results strongly suggest that human osteoblasts produce
G-CSE Osteoblast-derived G-CSF appears to be accessible
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Figure 4. Human CD34§ cells obtained by affinitypurificationof
nonadherentlow densitymononuclearbone marrowcells(CellProInc.)
were seededdirectlyinto 96-welltissueculture plates or onto confluent
osteocalcin+ c-kit ligand- human osteoblast monolayersat a final density of 104 cells/welland incubatedfor 14 d. The Results of one of two
experimentsare presented. Where indicatedvehicle(no AB), 10/Lg/well
of eitherneutralizinggoat anti-humanG-CSFserumor goat IgG serum
(control AB) were addeddaily(R&D Systems).Cell counts were determinedby manualhemocytometercountingand are reportedas mean -+ SD
(n = 3). The hematopoieticcellsrecoveredafter2 wk of coculturemaintainedan immature(23 _+6% myeloblasts/promyelocytes;51.7 + 5.5%
myelocytes/metamyelocytes;21 + 5% bands/polymorphonudearneutrophils; and 4.3 _+ 0.6% monocytes,treatmentwith anti-G-CSFreduced
the recoveryof band/polymorphonuclearneutrophils to 8.7 _+ 10%).
(Asterisk) Significantdifferencefromantibodyor vehiclecontrol,p <0.01.

to target cells when it is associated with osteobhst's ceil membrane. The possible mechanisms by which growth factors become cell associated or retained by components of the extracellular matrix and presented to target cells have not yet
been fully elucidated. Cell associated forms of M-CSF, c-kit
ligand, IL-lol, and matrix-associated forms of IL-3 and GMCSF have been described (20, 21, 25-30). The implications
of the experiments evaluating G-CSF production with bioassays vs. ELISA of conditioned osteoblast medium suggest
that either (a) immunoreactive G-CSF is diffusible only over
extremely short distances before inactivation; (b) the neutralizing G-CSF antibody does not have access to the microenvironment between osteoblasts and stem ceils; (c) directed
cell-cell transfer of G-CSF occurs between the osteoblasts
and hematopoietic progenitors, as has been reported for IL-2
(31); or (d) G-CSF or a closely related molecule is presented
to hematopoietic cells as a cell membrane associated protein
or bound in an active form to extracellular matrix molecules.
Of interest, at least three forms of G-CSF have been identified
on immunoblots, including 18-, 28-, and 32-kD forms (32).
To date it appears that the major secreted species is the 18-kD
form, whereas the biological nature of the higher molecular
mass proteins are unknown but possibly represent cellassociated or inactive protein precursors (32). We found no
evidence for G-CSF detectable in either the LPS-treated or
untreated osteoblast matrix fraction; until more extensive investigation of osteoblast's extracellular matrix is performed
however, these data do not rule out such a possibility.
It is interesting that the antibody to G-CSF neutralized
only 55% of the CD34 + cell's proliferative activity produced by the osteoblasts (Fig. 4). Thus, more than one factor
produced by osteoblasts may support the proliferation of hematopoietic stem cells. At present we do not know the identity of the molecule(s) which are responsible for this activity.
In preliminary experiments neutralizing antibody to IL-6 and
GM-CSF failed to affect proliferation of the NFS-60 cell line.
It is possible that unique osteoblast-derived cytokines are
responsible for proliferative effects on NFS-60 and CD34 +
cells. These observations suggest that stem cell self-renewal
is influenced by either osteoblast-derived cytokines or adhesive interactions between the two cell types or possibly both.
In sum, strong evidence indicates that human osteoblasts
produce cytokine signals that regulate hematopoiesis. Hematopoietic myeloid stem cell differentiation occurs in direct proximity to osteoblasts within the bone marrow cavity. We speculate that this intimate physical association established early
in life facilitates interactions between bone and hematopoietic cells. We determined that human osteoblasts are a constitutive source of the hematopoietic growth factor G-CSF.
If osteoblasts are a major source of the colony stimulating
cytokines in bone marrow, then understanding of the regulation of osteoblast-elaborated cytokines and the functional
consequences of alterations in osteoblast metabolism are critical
to our understanding of normal hematopoiesis.
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